Home | About PR | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |   Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
This article has been cited by
1Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Vânia Meireles,Tiago Rosado,Mário Barroso,Sofia Soares,Joana Gonçalves,Ângelo Luís,Débora Caramelo,Ana Simão,Nicolás Fernández,Ana Duarte,Eugenia Gallardo
Medicines.2019;6(1)35
[DOI]
2Cerebellum and endocannabinoid receptors: a new neurobiological link for mitragynine (Mitragyna speciosa Korth) abuse liability
Christian Müller
Journal of Addiction and Dependence.2015;1(1)1
[DOI]
3Methanolic extract of Mitragyna speciosa Korth leaf inhibits ethanol seeking behaviour in mice: involvement of antidopaminergic mechanism
Kamini Vijeepallam,Vijayapandi Pandy,Dharmani Devi Murugan,Murali Naidu
Metabolic Brain Disease.2019;34(6)1713
[DOI]
4Dose-Response Relationship, Acute Toxicity, and Therapeutic Index between the Alkaloid Extract ofMitragyna speciosaand Its Main Active Compound Mitragynine in Mice
Azadeh Sabetghadam,Visweswaran Navaratnam,Sharif Mahsufi Mansor
Drug Development Research.2013;74(1)23
[DOI]
5Experiences of Kratom Users: A Qualitative Analysis
Marc T. Swogger,Elaine Hart,Fire Erowid,Earth Erowid,Nicole Trabold,Kaila Yee,Kimberly A. Parkhurst,Brittany M. Priddy,Zach Walsh
Journal of Psychoactive Drugs.2015;47(5)360
[DOI]
6Understanding the Physicochemical Properties of Mitragynine, a Principal Alkaloid of Mitragyna speciosa, for Preclinical Evaluation
Surash Ramanathan,Suhanya Parthasarathy,Vikneswaran Murugaiyah,Enrico Magosso,Soo Tan,Sharif Mansor
Molecules.2015;20(3)4915
[DOI]
7Neurobiology of Kratom and its main alkaloid mitragynine
Farah W. Suhaimi,Nurul H.M. Yusoff,Rahimah Hassan,Sharif M. Mansor,Visweswaran Navaratnam,Christian P. Müller,Zurina Hassan
Brain Research Bulletin.2016;126(3)29
[DOI]
8Mitragyna speciosa Leaf Extract Exhibits Antipsychotic-Like Effect with the Potential to Alleviate Positive and Negative Symptoms of Psychosis in Mice
Kamini Vijeepallam,Vijayapandi Pandy,Thubasni Kunasegaran,Dharmani D. Murugan,Murali Naidu
Frontiers in Pharmacology.2016;7(3)29
[DOI]
9The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Andrew C. Kruegel,Oliver Grundmann
Neuropharmacology.2018;134(3)108
[DOI]
10Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats
Azadeh Sabetghadam,Surash Ramanathan,Sreenivasan Sasidharan,Sharif Mahsufi Mansor
Journal of Ethnopharmacology.2013;146(3)815
[DOI]
11From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
Zurina Hassan,Mustapha Muzaimi,Visweswaran Navaratnam,Nurul H.M. Yusoff,Farah W. Suhaimi,Rajakumar Vadivelu,Balasingam K. Vicknasingam,Davide Amato,Stephan von Hörsten,Nurul I.W. Ismail,Nanthini Jayabalan,Ammar I. Hazim,Sharif M. Mansor,Christian P. Müller
Neuroscience & Biobehavioral Reviews.2013;37(2)138
[DOI]
12Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Zurina Hassan,Oliver G. Bosch,Darshan Singh,Suresh Narayanan,B. Vicknasingam Kasinather,Erich Seifritz,Johannes Kornhuber,Boris B. Quednow,Christian P. Müller
Frontiers in Psychiatry.2017;8(2)138
[DOI]
13Endogenous opiates and behavior: 2010
Richard J. Bodnar
Peptides.2011;32(12)2522
[DOI]
  Feedback 
  Subscribe